- Home
- RDY vs CENT Comparison
RDY vs CENT Comparison
Compare RDY & CENT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDY
- CENT
- Stock Information
- Founded
- RDY 1984
- CENT 1955
- Country
- RDY India
- CENT United States
- Employees
- RDY N/A
- CENT N/A
- Industry
- RDY Biotechnology: Pharmaceutical Preparations
- CENT Consumer Specialties
- Sector
- RDY Health Care
- CENT Consumer Discretionary
- Exchange
- RDY Nasdaq
- CENT Nasdaq
- Market Cap
- RDY 2.1B
- CENT 2.4B
- IPO Year
- RDY N/A
- CENT N/A
- Fundamental
- Price
- RDY $13.94
- CENT $34.85
- Analyst Decision
- RDY Buy
- CENT Strong Buy
- Analyst Count
- RDY 1
- CENT 3
- Target Price
- RDY $17.00
- CENT $45.00
- AVG Volume (30 Days)
- RDY 2.9M
- CENT 167.4K
- Earning Date
- RDY 05-06-2025
- CENT 05-07-2025
- Dividend Yield
- RDY 3.50%
- CENT N/A
- EPS Growth
- RDY 2.68
- CENT N/A
- EPS
- RDY 0.75
- CENT 1.82
- Revenue
- RDY $3,637,607,642.00
- CENT $3,222,363,000.00
- Revenue This Year
- RDY $17.23
- CENT $2.77
- Revenue Next Year
- RDY $9.19
- CENT $2.16
- P/E Ratio
- RDY $18.46
- CENT $19.27
- Revenue Growth
- RDY 14.74
- CENT N/A
- 52 Week Low
- RDY $12.26
- CENT $32.17
- 52 Week High
- RDY $16.89
- CENT $47.48
- Technical
- Relative Strength Index (RSI)
- RDY 62.08
- CENT 47.35
- Support Level
- RDY $13.59
- CENT $34.58
- Resistance Level
- RDY $13.04
- CENT $36.08
- Average True Range (ATR)
- RDY 0.36
- CENT 1.37
- MACD
- RDY 0.11
- CENT -0.02
- Stochastic Oscillator
- RDY 97.78
- CENT 43.04
About RDY Dr. Reddy's Laboratories Ltd
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
About CENT Central Garden & Pet Company
Central Garden & Pet Co understands that home is central to life and has nurtured happy and healthy homes for over forty years. The segments of the company are the pet segment and garden segment. The company's trusted products are dedicated to helping lawns grow greener, gardens bloom bigger, pets live healthier and communities grow stronger. Central is home to a portfolio of more than sixty-five brands including Pennington, Nylabone, Kaytee, Amdro, and Aqueon, manufacturing and distribution capabilities, and a passionate, entrepreneurial growth culture. Central Garden and Pet is based in Walnut Creek, California, and has offices across North America and Europe.